Search company, investor...
Elephantech company logo


Founded Year



Series D | Alive

Total Raised


Last Raised

$14.46M | 5 mos ago

About Elephantech

Elephantech engages in the development of printed electronics manufacturing technology and the provision of related services. The company manufactures and sells flexible printed circuits (FPC) manufactured using inkjet printing and electroless copper plating. The firm was formerly known as AgIC. It was founded in 2014 and is based in Tokyo, Japan.

Headquarters Location

4-3-8 Hatchobori Chuo-ku

Tokyo, 104-0032,


+81 3-6280-3271

Elephantech's Product Videos

Compete with Elephantech?

Ensure that your company and products are accurately represented on our platform.

Elephantech's Products & Differentiators


    Flexible Printed Circuit boards which is produced by metal inkjet printing technology and copper plating.

Expert Collections containing Elephantech

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Elephantech is included in 2 Expert Collections, including Advanced Materials.


Advanced Materials

1,281 items

Startups developing new or improved materials (chemicals, alloys, etc.) that provide physical or functional advantages to basic materials.


Semiconductors, Chips, and Advanced Electronics

6,282 items

Companies in this collection develop everything from microprocessors to flash memory, integrated circuits specifically for quantum computing and artificial intelligence to OLED for displays, massive production fabs to circuit design firms, and everything in between.

Latest Elephantech News

AGIC Capital Acquires Majority Stake in ATEC Pharmatechnik GmbH

Nov 30, 2022

By SÖRUP, Germany & MUNICH, Germany–(BUSINESS WIRE)–AGIC Capital (“AGIC”), a growth-oriented private equity firm with $2.2 billion of assets under management, today announced that it had acquired a majority stake in ATEC Pharmatechnik GmbH (“ATEC” or “the Company”). The sellers, ATEC’s founder & CEO, Hans-Werner Mumm, and family-backed Mittelstand investor HANNOVER Finanz Group, will remain invested in the Company, and Hans-Werner Mumm will continue to act as its CEO. ATEC is a leading manufacturer of aseptic processing solutions, primarily used in pharmaceutical manufacturing and bioprocessing applications, with a customer base that includes the top 10 global pharmaceutical companies. ATEC’s products include stopper and cap processing systems used for aseptic filling, RTP transfer ports and ancillary single-use transfer bag solutions. These mission-critical technologies enable ATEC’s customers to establish safe and reliable manufacturing process environments. This is anticipated to be the first of several acquisitions as AGIC builds a specialty process technologies platform focused on pharmaceutical and biopharmaceutical end markets. Hans-Werner Mumm, CEO of ATEC commented, “We are excited to partner with AGIC, a firm that shares our passion for providing our customers with safer aseptic transfer technologies, which are critical to the future of medicine. We look forward to expanding our critical role in pharmaceutical manufacturing and bioprocessing as we invest in our next phase of growth.” Erik Yankulin, Managing Director at AGIC, added, “ATEC supports the production of life-saving therapies by providing best-in-class aseptic transfer technologies to pharmaceutical and biopharmaceutical companies. Specifically, the Company’s products provide industry-leading solutions for handling sterile drug products across the most demanding pharmaceutical manufacturing applications in the areas of diabetes, oncology and other therapies. We are excited to support ATEC through investments into new product development, go-to-market capabilities, and add-on acquisitions.” Frank Löffler, Partner at HANNOVER Finanz added, “We have worked closely with Hans-Werner and ATEC’s management team since 2018 to grow the business, its customer base and innovative product offering. We strongly believe in the company’s potential and wish AGIC as the future majority shareholder the best of success in driving the next chapter of ATEC’s growth.” ATEC and HANNOVER Finanz were advised by Macquarie Capital with Latham & Watkins LLP advising the sellers, while AGIC was supported by White & Case LLP in connection with the acquisition. About AGIC Capital AGIC is a growth-oriented private equity firm that seeks to invest in thriving middle-market businesses focused on advanced industrial and healthcare technologies in Europe & beyond. AGIC’s differentiated investment strategy combines deep business model expertise, proactive thematic research, an unrelenting focus on the upside and a collaborative, management-first approach to value creation. Launched in 2015, AGIC currently has $2.2 billion in assets under management. The firm’s more than 25 professionals are based in Europe and Asia. For more information about AGIC’s investment philosophy, visit . About ATEC Pharmatechnik GmbH ATEC Pharmatechnik GmbH is a leader in stopper and cap processing solutions used for aseptic filling with patented process technology in pharmaceutical applications. ATEC’s products are used primarily in pharmaceutical manufacturing and bioprocessing applications and comprise stopper and cap processing systems used for aseptic filling, RTP transfer ports and ancillary single-use transfer bags and spare parts. The Company is headquartered in Sörup, Germany. About HANNOVER Finanz HANNOVER Finanz Group has been a sought-after private equity partner for medium sized enterprises in all industries for more than 40 years now. The private equity firm is based in Hanover and Vienna and was founded in 1979 as one of the first providers of venture capital in Germany. Currently, the HANNOVER Finanz Group has over 700 million Euros of assets under management across around 40 companies in Germany and Austria. Since its foundation, the Group has invested an accumulated total of over one and a half billion Euros and has successfully completed more than 250 projects. For more information, please visit Contacts

Elephantech Frequently Asked Questions (FAQ)

  • When was Elephantech founded?

    Elephantech was founded in 2014.

  • Where is Elephantech's headquarters?

    Elephantech's headquarters is located at 4-3-8 Hatchobori, Tokyo.

  • What is Elephantech's latest funding round?

    Elephantech's latest funding round is Series D.

  • How much did Elephantech raise?

    Elephantech raised a total of $38.1M.

  • Who are the investors of Elephantech?

    Investors of Elephantech include Mitsubishi Gas Chemical Company, ANRI, Nanobank, Nose, Nose Investment and 27 more.

  • Who are Elephantech's competitors?

    Competitors of Elephantech include Nano Dimension.

  • What products does Elephantech offer?

    Elephantech's products include P-Flex.

  • Who are Elephantech's customers?

    Customers of Elephantech include Fukuda.

Compare Elephantech to Competitors

nScrypt Logo

nScrypt designs and manufactures microdispensing, direct digital manufacturing equipment and solutions for industrial applications. It is based in Orlando, Florida.

Nano Dimension Logo
Nano Dimension

Nano Dimension (NASDAQ: NNDM) designs a 3D printer that uses advanced nanoparticle inks to enable in-house rapid prototyping of multilayer printed circuit boards (PCBs) and 3D circuitry. The company was founded in 2012 and is based in Waltham, Massachusetts.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.